It is similar in action to verapamil.
Actions:
It:
1. relieves spasm of coronary artery
2. causes a decrease in the AV conduction
3. causes a decrease in the firing time of the sinus node pacemaker
4. decrease heart rate
5. cause a depressed blood pressure
Therapeutic uses:
It is used for
1. variant angina.
2. Atrial fibrillation/flutter
3. Raynaud’s syndrome
Pharmacokinetics:
It undergoes hepatic metabolism.
Friday, March 18, 2011
Verapamil
It is a diphenylalkylamine.
Action:
It causes a decrease in the AV conduction of the heart leading to decreased heart rate and demand for oxygen. It also causes a decrease in the firing time of the sinus node pacemaker.
Verapamil may also produce local anesthetic action (due to less effective blockade of sodium channels).
Verapamil also cause inhibition of insulin release.
Pharmacokinetics:
The drug shows hepatic metabolism.
Administration:
Orally, Intravenously
Therapeutic uses:
It is used for supraventricular tachyarrhythmias.
Adverse effects:
Constipation
Contraindications:
It is contraindicated in:
1. Patients with already decreased cardiac function.
2. Patients with abnormalities of atrioventricular conduction.
Precautions:
It should be used with caution in patients with liver function abnormalities.
It should also be used with caution in patients taking digoxin as it may increase digoxin level.
Action:
It causes a decrease in the AV conduction of the heart leading to decreased heart rate and demand for oxygen. It also causes a decrease in the firing time of the sinus node pacemaker.
It has more negative inotropic effect as compared to nifedipine but has weak vasodilation effect.
Verapamil may also produce local anesthetic action (due to less effective blockade of sodium channels).
Verapamil also cause inhibition of insulin release.
Pharmacokinetics:
The drug shows hepatic metabolism.
Administration:
Orally, Intravenously
Therapeutic uses:
It is used for supraventricular tachyarrhythmias.
Adverse effects:
Constipation
Contraindications:
It is contraindicated in:
1. Patients with already decreased cardiac function.
2. Patients with abnormalities of atrioventricular conduction.
Precautions:
It should be used with caution in patients with liver function abnormalities.
It should also be used with caution in patients taking digoxin as it may increase digoxin level.
Nifedipine
It is a dihydropyridine derivative.
Actions:
It causes vasodilation of the arteries. It may cause peripheral vasodilation resulting in the decrease of total peripheral vascular resistance, resulting in decline of blood pressure declining oxygen requirement of the heart muscles.
It rarely affects on cardiac conduction or heart rate.
It may also decrease insulin secretion.
Dosage and administration:
It is administered orally and is available as extended release tablets.
Pharmacokinetics:
It undergoes hepatic metabolism and the metabolites (metabolism products) are excreted in urine and feces.
Therapeutic uses:
It is Useful in the treatment of variant angina (due to spontaneous coronary spasm).
Adverse effects:
Flushing, headache, hypotension, reflex tachycardia, peripheral edema, constipation,
Actions:
It causes vasodilation of the arteries. It may cause peripheral vasodilation resulting in the decrease of total peripheral vascular resistance, resulting in decline of blood pressure declining oxygen requirement of the heart muscles.
It rarely affects on cardiac conduction or heart rate.
It may also decrease insulin secretion.
Dosage and administration:
It is administered orally and is available as extended release tablets.
Pharmacokinetics:
It undergoes hepatic metabolism and the metabolites (metabolism products) are excreted in urine and feces.
Therapeutic uses:
It is Useful in the treatment of variant angina (due to spontaneous coronary spasm).
Adverse effects:
Flushing, headache, hypotension, reflex tachycardia, peripheral edema, constipation,
Amlodipine
It does not affect the heart rate or cardiac output.
Structure:
Other names:
Its half life is 34 hours.
Therapeutic uses:
It is used for vasospastic chronic stable angina and hypertension.
Brand Names:
References:
Amlodipine on http://www.drugbank.ca/drugs/DB00381 Updated on November 10, 2010. Accessed April 17, 2011.
Structure:
 |
| Credit: Rxlist |
- Amlodipine Benzenesulfonate
- Amlodipine Besilate
- Amlodipine Besylate
- Amlodipine Free Base
- Amlodipino [Spanish]
- Amlodipinum [Latin]
Its half life is 34 hours.
Therapeutic uses:
It is used for vasospastic chronic stable angina and hypertension.
Brand Names:
- Amlip (Venezuela)
- Amlocard (AWD (Germany))
- Amlodis (Eczacibasi (Turkey))
- Amlomed
- Amlopick
- Amvaz (Reddy (Malaysia))
- Coroval (Sandoz (Argentina))
- Lipinox (Commonly misspelled Lipinok, Lepenox,Lilinox,Lipinux)
- Norvasc (Pfizer)
- Azor (amlodipine + olmesartan)
- Caduet (amlodipine + atorvastatin)
- Coroval B (amlodipine + benazepril)
- Exforge (amlodipine + valsartan)
- Lotrel (amlodipine + benazepril)
References:
Amlodipine on http://www.drugbank.ca/drugs/DB00381 Updated on November 10, 2010. Accessed April 17, 2011.
Thursday, March 17, 2011
Calcium
Role of calcium:
Calcium is one of the essential components for contraction of muscles. Calcium is also responsible for the excitation-secretion coupling in exocrine and endocrine glands.
Calcium channels:
Calcium got entry into cells through pores in the membrane. These particular pores are named as calcium channels.
Types of calcium channels:
Action of calcium:
The calcium influx is elevated in ischemia as a result of membrane depolarization that is caused by reduced oxygen supply. This depolarization is voltage operated and is done by L- type channels. This increase results in the rise of activity of many ATP-consuming enzymes resulting in the reduction of energy stores. This leads in increase of ischemic effects.
Sometimes channels are opened by receptors for neurotransmitters and therefore this activation is referred to as receptor operated.
Mechanism of action of calcium entry blockers:
Some of the calcium entry blockers cause arteriolar dilatation; resulting from the decreased oxygen demand of the heart muscles, by affecting the heart directly i.e. causes the heart to beat slowly. They are, therefore, also working as vasodilators resulting in the decrease in smooth muscle tone and vascular resistance.
Actions:
Calcium entry blockers work better when the tissue is depolarized. At therapeutic doses, these agents affect on the resistance of vascular smooth muscle and the muscles of the heart.
They also decrease blood pressure.
They have negative chronotropic and inotropic effect resulting in less oxygen demand.
The prominent effect (anti-anginal) in angina caused by exercise and unstable angina is achieved by the reduction in cardiac afterload. On the other hand, vasospastic angina is relieved by dilatation of the coronary arteries and arterioles.
Calcium plays essential role in
1. contraction of muscles of the heart
2. regulating the firmness of the smooth muscles
Calcium get entry to the muscle cells through special channels namely voltage gated calcium channels. As a result, the release of calcium from the sarcoplasmic reticulum and mitochondria is initiated. This causes an additional elevation in the level of calcium in the fluid part of the cytoplasm (cytosol).
Therapeutic Uses:
They are also used in:
1. Systemic hypertension
2. Peripheral vascular disease
3. Hypertrophic subaortic stenosis
4. Stroke
5. Migraine
6. Suppression of atherogenesis
Adverse effects:
Hypotension, Headache, flushing, dizziness (These are caused by vasodilatory effects of calcium entry blockers).
Bradycardia (This is caused by less SA automaticity).
Heart block (This may be caused by reduced AV conduction).
Congestive heart failure (may be due to reduced contraction of the heart muscle).
Constipation (may be due to gentle excitation-contraction uncoupling in GI smooth muscle).
Calcium entry blockers
Much of the calcium entry blockers are dihydropyridines.
Clacium entry blockers include Amlodipine, Bepridil, Diltiazim, Felodipine, Isradipine, Nicardipine, Nifedipine, Nimodipine, Nisoldipine, Nitrendipine, Verapamil
Mechanism of action:
They get bind to receptors present on L-type calcium channels (voltage gated calcium channels) resulting in the blockage of calcium channels in the heart and in the smooth muscles of the coronary and peripheral vessels. This causes inhibition of calcium inflow to the cardiac and smooth muscle cells resulting in relaxation of muscles.
Actions:
Calcium channel blockers cause relaxation of the arterioles and veins but relaxation is more pronounced in arterioles than in the veins.
Calcium channel blockers causes dilatation of the coronary arterioles and coronary arteries and reduction of coronary artery spasm. This results in elevated oxygen supply to the muscles of the heart in patients with variant angina.
On the other hand, dilatation of the peripheral arterioles causes a decrease in total peripheral vascular resistance leading to decreased blood pressure. This affect is mainly caused by nifedipine. This causes a decrease in oxygen requirement of the muscles of the heart.
All of these factors are responsible for less oxygen requirement in patients with angina:
1. Reduced generation of impulses in SA node and reduced conduction in AV node
2. Reduced cardiac contractility and output
Verapamil and diltiazim show more pronounced effects on the heart.
Verapamil blocks release of insulin.
Verapamil blocks sodium channels less effectively, so that is why it has slight local anesthetic activity.
Pharmacokinetics:
They have a half life of about 2.5-8 hours, when used orally.
Therapeutic uses:
In hypertension when accompanied by angina, diabetes and/or asthma.
They are also used for angina pectoris, hypertrophic cardiomyopathy, migraine and atherosclerosis.
Verapamil is used to treat migraine, angina and supraventricular tachyarrhythmias.
Adverse effects:
They may cause dizziness, bradycardia, cardiac arrest, hypotension, nausea, constipation (in about 10% of patients), flushing and headache.
Contraindications:
These are contraindicated in patients with
1. cardiogenic shock
2. severe hypotension
Clacium entry blockers include Amlodipine, Bepridil, Diltiazim, Felodipine, Isradipine, Nicardipine, Nifedipine, Nimodipine, Nisoldipine, Nitrendipine, Verapamil
Mechanism of action:
They get bind to receptors present on L-type calcium channels (voltage gated calcium channels) resulting in the blockage of calcium channels in the heart and in the smooth muscles of the coronary and peripheral vessels. This causes inhibition of calcium inflow to the cardiac and smooth muscle cells resulting in relaxation of muscles.
Actions:
Calcium channel blockers cause relaxation of the arterioles and veins but relaxation is more pronounced in arterioles than in the veins.
Calcium channel blockers causes dilatation of the coronary arterioles and coronary arteries and reduction of coronary artery spasm. This results in elevated oxygen supply to the muscles of the heart in patients with variant angina.
On the other hand, dilatation of the peripheral arterioles causes a decrease in total peripheral vascular resistance leading to decreased blood pressure. This affect is mainly caused by nifedipine. This causes a decrease in oxygen requirement of the muscles of the heart.
All of these factors are responsible for less oxygen requirement in patients with angina:
1. Reduced generation of impulses in SA node and reduced conduction in AV node
2. Reduced cardiac contractility and output
Verapamil and diltiazim show more pronounced effects on the heart.
Verapamil blocks release of insulin.
Verapamil blocks sodium channels less effectively, so that is why it has slight local anesthetic activity.
Pharmacokinetics:
They have a half life of about 2.5-8 hours, when used orally.
Therapeutic uses:
In hypertension when accompanied by angina, diabetes and/or asthma.
They are also used for angina pectoris, hypertrophic cardiomyopathy, migraine and atherosclerosis.
Verapamil is used to treat migraine, angina and supraventricular tachyarrhythmias.
Adverse effects:
They may cause dizziness, bradycardia, cardiac arrest, hypotension, nausea, constipation (in about 10% of patients), flushing and headache.
Contraindications:
These are contraindicated in patients with
1. cardiogenic shock
2. severe hypotension
Wednesday, March 16, 2011
Classification of Anti-Anginal Drugs
Classification according to differences in agents/groups:
Organic nitrites and nitrates:
Nitrites:
Amylnitrite,
Nitrates:
Erythrityl tetranitrate, Isosorbide dinitrate, isosorbide mononitrate, nitroglycerin, Pentaerythritol tetranitrate
β adrenoceptor blockers:
Nonselective β adrenoceptor blockers:
Propranolol, Timolol, Nadolol
Selective β1 adrenoceptor blocker:
Acebutolol, Atenolol, Metoprolol, Esmolol
Ca2+ entry blockers:
Amlodipine, Bepridil, Diltiazim, Felodipine, Isradipine, Nicardipine, Nifedipine, Nimodipine, Nisoldipine, Nitrendipine, Verapamil
Other vasodilator agents:
Dipyridamole, Nylidrin
Miscellaneous agents:
Camphotamide, Prenylamine
Plant products:
Papaverine
Classification according to types of angina pectoris:
Stable angina:
Nitroglycerin,
Variant angina:
Nitroglycerin, calcium entry blockers
Organic nitrites and nitrates:
Nitrites:
Amylnitrite,
Nitrates:
Erythrityl tetranitrate, Isosorbide dinitrate, isosorbide mononitrate, nitroglycerin, Pentaerythritol tetranitrate
β adrenoceptor blockers:
Nonselective β adrenoceptor blockers:
Propranolol, Timolol, Nadolol
Selective β1 adrenoceptor blocker:
Acebutolol, Atenolol, Metoprolol, Esmolol
Ca2+ entry blockers:
Amlodipine, Bepridil, Diltiazim, Felodipine, Isradipine, Nicardipine, Nifedipine, Nimodipine, Nisoldipine, Nitrendipine, Verapamil
Other vasodilator agents:
Dipyridamole, Nylidrin
Miscellaneous agents:
Camphotamide, Prenylamine
Plant products:
Papaverine
Classification according to types of angina pectoris:
Stable angina:
Nitroglycerin,
Variant angina:
Nitroglycerin, calcium entry blockers
Subscribe to:
Posts (Atom)
-
Q: What do you know about ergot alkaloids? Ans: These include alkaloids which we get from the ergot fungus Claviceps purpurea or derived ...
-
(For detailed study of Pharmaceutical Incompatibility Click here) Multiple Choice Questions (MCQs) from Pharmaceutical Incompatibility in ...
-
Multiple Choice Questions (MCQs) of Powders and Granules from Pharmaceutics 1. _______ powders consist of more than one ingredients. a. Si...
